THE USE OF REAL-WORLD DATA IN DECISION MAKING FOR ONCOLOGY: A REVIEW OF RECENT HEALTH TECHNOLOGY APPRAISALS IN THE UNITED KINGDOM

被引：0
|
作者：
Koufopoulou, M. [1 ]
Wissinger, E. [2 ]
Oladapo, T. [1 ]
Stewart, F. [3 ]
Depalma, S. [3 ]
Devani, D. [2 ]
Rangi, N. D. [1 ]
Fusco, N. [2 ]
机构：
[1] AmerisourceBergen, London, England
[2] AmerisourceBergen, Carollton, TX USA
[3] AmerisourceBergen, Hannover, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA24
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [11] Real-world data in the United Kingdom: opportunities and challenges
    McDonald, Laura
    Lambrelli, Dimitra
    Wasiak, Radek
    Ramagopalan, Sreeram V.
    BMC MEDICINE, 2016, 14
  • [12] Payer perceptions of the use of real-world evidence in oncology-based decision making
    Brixner, Diana
    Biskupiak, Joseph
    Oderda, Gary
    Burgoyne, Douglas
    Malone, Daniel C.
    Arondekar, Bhakti
    Niyazov, Alexander
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (08): : 1096 - 1105
  • [13] Transferability of real-world data across borders for regulatory and health technology assessment decision-making
    Jaksa, Ashley
    Arena, Patrick J.
    Chan, Kelvin K. W.
    Ben-Joseph, Rami H.
    Jonsson, Pall
    Campbell, Ulka B.
    FRONTIERS IN MEDICINE, 2022, 9
  • [14] Recent advancement in integrating artificial intelligence and information technology with real-world data for clinical decision-making in China: A scoping review
    Liao, Xiwen
    Yao, Chen
    Zhang, Jun
    Liu, Larry Z.
    JOURNAL OF EVIDENCE BASED MEDICINE, 2023, 16 (04) : 534 - 546
  • [15] THE USE OF REAL-WORLD EVIDENCE IN NICE HEALTH TECHNOLOGY APPRAISALS: A QUANTITATIVE REVIEW OF SUBMISSIONS TO NICE BETWEEN 2022 AND 2024
    Aidarous, A.
    Tahir, H.
    Diribe, O.
    Allen, R.
    VALUE IN HEALTH, 2024, 27 (12) : S358 - S358
  • [16] Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making
    Franklin, Jessica M.
    Glynn, Robert J.
    Martin, David
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (04) : 867 - 877
  • [17] ANALYSIS OF INTENSITY OF USE OF REAL-WORLD DATA IN SINGLE TECHNOLOGY APPRAISALS OF CANCER DRUGS BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
    Kang, J.
    Cairns, J.
    VALUE IN HEALTH, 2024, 27 (06) : S252 - S252
  • [18] A SYSTEMATIC LITERATURE REVIEW ON THE USE OF REAL-WORLD EVIDENCE IN NICE TECHNOLOGY APPRAISALS INDICATED FOR MULTIPLE MYELOMA
    Dempsey, J.
    Tsang, C.
    Duffield, C.
    VALUE IN HEALTH, 2023, 26 (12) : S520 - S520
  • [19] HEALTH TECHNOLOGY ASSESSMENT (HTA) CASE STUDIES: COMPARING ACCEPTABILITY OF REAL-WORLD EVIDENCE (RWE) IN APPRAISALS FOR ONCOLOGY MEDICINES
    Zong, J.
    Pan, X.
    Rojubally, A.
    Jiao, X.
    Bruno, A.
    Bergeson, J. Gdovin
    VALUE IN HEALTH, 2023, 26 (12) : S321 - S321
  • [20] Analysis of factors associated with use of real-world data in single technology appraisals of cancer drugs by the National Institute for Health and Care Excellence
    Kang, Jiyeon
    Cairns, John
    JOURNAL OF CANCER POLICY, 2024, 42
12345